hotspot -WSS

hotspot

author：entertainment 2025-09-29 19:14:26 - browse：4

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

explore

hotspot

WSS

Lasker Awards 2023: Winners in biomedical research

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Intermittent fasting comes with a heart risk? Not so fast

How AI helped researchers track recovery from depression

Lasker Awards 2023: Winners in biomedical research

Nurses recount patients attacks

focus

hotspot

hotspot

Walensky prepares to leave CDC — and Congress — behind

CommonSpirit Health keeps growing, even as it loses money

Duchenne breakthrough therapy leaves behind pioneering families

How AI helped researchers track recovery from depression

At least 13 dead in Texas as scorching temps continue

Argenx readies a blockbuster opportunity with drug for autoimmune disease

Medical records are filled with copy

App could help diagnose ear infections more accurately — and at home

Cancer drug shortages should be causing more outrage

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

knowledge

Orchard's therapy for neuron disease in children wins FDA approval

Creating egg and sperm cells from stem cells raises ethical issues

Thermo Fisher plant for manufacturing gene therapies to expand

FDA panel to weigh approval of NurOwn, controversial ALS drug

Medical student insurance fails on mental health care coverage

UnitedHealth increases loan offers after Change Healthcare outage

explore

explore

hotspot

focus